Brief: Hls Therapeutics Announces Reimbursement For Vascepa Under Nova Scotia's Provincial Drug Plan
02/07/2025 12:03
July 2 (Reuters) - HLS Therapeutics Inc HLS.TO: HLS THERAPEUTICS ANNOUNCES REIMBURSEMENT FOR VASCEPA® UNDER NOVA SCOTIA'S PROVINCIAL DRUG PLAN HLS THERAPEUTICS INC - PLA WITH NOVA SCOTIA PHARMACARE EFFECTIVE JULY 1, 2025 Source text: ID:nCNWLl02Na Further company coverage: HLS.TO (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease